English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

treated with cyclophosphamide and corticosteroids, while 2 individuals received cyclophosphamide and corticosteroids after rituximab. After a median follow up time of 29.5 months (IQR 20-54.5), median sCr and median eGFR were 1.2 mg/dl (IQR 1.08-2.2) and 52 mL/min/1.73 m (IQR 27-73) respectively. Median proteinuria was 0.94 mg/day (IQR 0.23-4.35). Among patients who received immunosuppressive therapy, one patient did not respond to the treatment, one patient progressed to ESRD two years after diagnosis, whereas partial and complete renal response occurred each in 2 patients. One patient developed small cell lung cancer twelve years after the presentation of the disease.

SP160IS AGE A DETERMINANT OF THE KIDNEY OUTCOME IN BIOPSY-PROVEN GLOMERULOPATHIES?